Search results
To Your Good Health: Jardiance prescription comes with too many urinary issues
The Marshall News Messenger· 19 hours agoROACH: I am a 64-year-old male, and my A1C level has been averaging around 7.4% for a number of...
Type 2 diabetes: New guidelines on using GLP-1 drugs such as Ozempic
Medical News Today· 6 days agoResearchers report that GLP-1 and SGLT-2 drugs can help people with type 2 diabetes control blood...
Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 20 hours agoAlso, continued higher demand and volume growth for Lilly’s key growth drugs (select products...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 19 hours agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap...
Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?
Investor's Business Daily· 7 days agoSales from Mounjaro grew nearly eightfold to $2.21 billion, handily beating forecasts. Sales of...
Op-Ed | Higher drug prices jeopardize the health of New Yorkers | amNewYork
amNewYork· 7 days agoIf you or your loved ones have had similar experiences at the pharmacy counter, it’s important you...
Liz Weston: Leaving property to multiple heirs can cause conflict
OregonLive.com· 5 days agoDear Liz: My wife and I plan to leave our house to our four children. Answer: You’ve identified some...
Eli Lilly and Company (NYSE:LLY) Shares Sold by Knights of Columbus Asset Advisors LLC
ETF DAILY NEWS· 3 days agoKnights of Columbus Asset Advisors LLC lessened its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 25.6% in the 4th quarter, according to the company in its most recent filing with ...
University of Iowa pharmacy counselor saves millions for patients
The Gazette· 4 days agoWhen Wendy Ostrem graduated from pharmacy school at the University of Iowa in 1986, pharmacies were...
Zacks Research Analysts Reduce Earnings Estimates for Eli Lilly and Company (NYSE:LLY)
ETF DAILY NEWS· 5 days agoEli Lilly and Company (NYSE:LLY – Free Report) – Research analysts at Zacks Research decreased their Q1 2025 EPS estimates for Eli Lilly and Company in a research report issued on Wednesday, ...